TY - JOUR
T1 - Use of mammographic screening by HIV-infected women in the Women’s Interagency HIV Study (WIHS)
AU - Preston-Martin, Susan
AU - Kirstein, Lynn M.
AU - Pogoda, Janice M.
AU - Rimer, Barbara
AU - Melnick, Sandra
AU - Masri-Lavine, Lena
AU - Silver, Sylvia
AU - Hessol, Nancy
AU - French, Audrey L.
AU - Feldman, Joseph
AU - Sacks, Henry S.
AU - Deely, Maureen
AU - Levine, Alexandra M.
N1 - Funding Information:
1This work was funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute, the National Institute of Child Health and Human Development, the National Institute on Drug Abuse, the National Institute of Dental Research, the Agency for Health Care Policy and Research, and the Centers for Disease Control and Prevention, Contract Nos. U01-AI-35004, U01-AI-31834, U01-AI-34994, AI-34989, U01-HD-32632 (NICHD), U01-AI-34993, U01-AI-42590, and N01-AI-35161.
PY - 2002/3
Y1 - 2002/3
N2 - Background. Although HIV-positive women may be less likely than women in general to receive mammography due to socioeconomic disadvantage, HIV diagnosis may increase opportunities for medical interactions which encourage mammography. Methods. HIV-positive (2, 059) and HIV-negative (569) Women's Interagency HIV Study (WIHS) participants reported ever/never history of mammography at baseline (in 1994, 1995) and, at each 6-month follow-up visit, if they had been screened since their last visit. National Health Interview Survey (NHIS) data for 1994 were used to compare WIHS participants to U.S. women. Factors independently related to mammography were determined using logistic regression for baseline data and proportional hazards for follow-up data. Results were adjusted for age. Results. Among women ≥40, fewer WIHS women, regardless of HIV status, reported screening than U.S. women (67% HIV-positive, 62% HIV-negative, 79% NHIS; P < 0.0001). First-time screening while on study was associated with being HIV-positive [rate ratio (95% confidence interval) = 1.6 (1.1, 2.3)]. Factors independently associated with screening were related to health care access and usage. Conclusions. WIHS women, a disadvantaged population, reported less mammography than the general population. HIV-positive women reported more screening than HIV-negative women, possibly because of greater opportunity to interact with the health care system.
AB - Background. Although HIV-positive women may be less likely than women in general to receive mammography due to socioeconomic disadvantage, HIV diagnosis may increase opportunities for medical interactions which encourage mammography. Methods. HIV-positive (2, 059) and HIV-negative (569) Women's Interagency HIV Study (WIHS) participants reported ever/never history of mammography at baseline (in 1994, 1995) and, at each 6-month follow-up visit, if they had been screened since their last visit. National Health Interview Survey (NHIS) data for 1994 were used to compare WIHS participants to U.S. women. Factors independently related to mammography were determined using logistic regression for baseline data and proportional hazards for follow-up data. Results were adjusted for age. Results. Among women ≥40, fewer WIHS women, regardless of HIV status, reported screening than U.S. women (67% HIV-positive, 62% HIV-negative, 79% NHIS; P < 0.0001). First-time screening while on study was associated with being HIV-positive [rate ratio (95% confidence interval) = 1.6 (1.1, 2.3)]. Factors independently associated with screening were related to health care access and usage. Conclusions. WIHS women, a disadvantaged population, reported less mammography than the general population. HIV-positive women reported more screening than HIV-negative women, possibly because of greater opportunity to interact with the health care system.
KW - Cohort study
KW - HIV
KW - Health services accessibility
KW - Mammography
UR - http://www.scopus.com/inward/record.url?scp=0036351380&partnerID=8YFLogxK
U2 - 10.1006/pmed.2001.1003
DO - 10.1006/pmed.2001.1003
M3 - Article
C2 - 11902857
AN - SCOPUS:0036351380
SN - 0091-7435
VL - 34
SP - 386
EP - 392
JO - Preventive Medicine
JF - Preventive Medicine
IS - 3
ER -